Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma ; volume:30 ; number:1 ; day:5 ; month:10 ; year:2011 ; pages:1-7 ; date:12.2011
Journal of experimental & clinical cancer research ; 30, Heft 1 (5.10.2011), 1-7, 12.2011
- Creator
-
Kuwahara, Akiko
Yamamori, Motohiro
Kadoyama, Kaori
Nishiguchi, Kohshi
Nakamura, Tsutomu
Miki, Ikuya
Tamura, Takao
Okuno, Tatsuya
Omatsu, Hideaki
Sakaeda, Toshiyuki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-9966-30-94
- URN
-
urn:nbn:de:101:1-2021081500364982528328
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kuwahara, Akiko
- Yamamori, Motohiro
- Kadoyama, Kaori
- Nishiguchi, Kohshi
- Nakamura, Tsutomu
- Miki, Ikuya
- Tamura, Takao
- Okuno, Tatsuya
- Omatsu, Hideaki
- Sakaeda, Toshiyuki
- SpringerLink (Online service)
Other Objects (12)
TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
Therapie des fortgeschrittenen kolorektalen Karzinoms: Ergebnisse der systemischen Folinsäure/5-Fluorouracil- [Folinsäure-Fluorouracil-] und der regionalen 5-Fluorouracil-Therapie [Fluorouracil-Therapie]
Hochdosierte 5-Fluorouracil-Therapie [Fluorouracil-Therapie] bei kolorektelen Tumoren
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients
Auswertung einer Chemotherapie-Studie mit Cisplatin und 5-Fluorouracil [Fluorouracil] bei Patienten mit fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereiches
Adjuvante Chemotherapie mit Cisplatin und 5-Fluorouracil [Fluorouracil] als einarmige prospektive Therapiestudie am Plattenepithelkarzinom von Lippen, Mundhöhle und Oropharynx
Life-Threatening Reaction with Topical 5-Fluorouracil
TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
Therapie des fortgeschrittenen kolorektalen Karzinoms: Ergebnisse der systemischen Folinsäure/5-Fluorouracil- [Folinsäure-Fluorouracil-] und der regionalen 5-Fluorouracil-Therapie [Fluorouracil-Therapie]
Hochdosierte 5-Fluorouracil-Therapie [Fluorouracil-Therapie] bei kolorektelen Tumoren
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients
Auswertung einer Chemotherapie-Studie mit Cisplatin und 5-Fluorouracil [Fluorouracil] bei Patienten mit fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereiches
Adjuvante Chemotherapie mit Cisplatin und 5-Fluorouracil [Fluorouracil] als einarmige prospektive Therapiestudie am Plattenepithelkarzinom von Lippen, Mundhöhle und Oropharynx
Life-Threatening Reaction with Topical 5-Fluorouracil
TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
Therapie des fortgeschrittenen kolorektalen Karzinoms: Ergebnisse der systemischen Folinsäure/5-Fluorouracil- [Folinsäure-Fluorouracil-] und der regionalen 5-Fluorouracil-Therapie [Fluorouracil-Therapie]
Hochdosierte 5-Fluorouracil-Therapie [Fluorouracil-Therapie] bei kolorektelen Tumoren
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients
Auswertung einer Chemotherapie-Studie mit Cisplatin und 5-Fluorouracil [Fluorouracil] bei Patienten mit fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereiches
Adjuvante Chemotherapie mit Cisplatin und 5-Fluorouracil [Fluorouracil] als einarmige prospektive Therapiestudie am Plattenepithelkarzinom von Lippen, Mundhöhle und Oropharynx